These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6184353)

  • 21. 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.
    Silverman RH; Cayley PJ; Wreschner DH; Knight M; Gilbert CS; Brown RE; Kerr IM
    Tex Rep Biol Med; 1981-1982; 41():479-86. PubMed ID: 6189212
    [No Abstract]   [Full Text] [Related]  

  • 22. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
    Kanda T; Yokoyama T; Suzuki T; Murata K
    Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CFUs proliferative responses to exogenous soluble and immobilized cyclic nucleotides].
    Fedorov NA; Koreshkova NA; Stepanova SB; Guliaev NN
    Dokl Akad Nauk SSSR; 1980; 250(1):250-2. PubMed ID: 6247130
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.
    Malkovský M; Asherson GL; Chandler P; Colizzi V; Watkins MC; Zembala M
    J Immunol; 1983 Feb; 130(2):785-90. PubMed ID: 6217254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes.
    Reed SG; Barral-Netto M; Inverso JA
    J Immunol; 1984 Jun; 132(6):3116-9. PubMed ID: 6725947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of in vitro generation of cell-mediated cytotoxicity. In vitro induction of suppressor T lymphocytes by thymosin.
    Marshall GD; Thurman GB; Goldstein AL
    J Reticuloendothel Soc; 1980 Aug; 28(2):141-9. PubMed ID: 6447785
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of normal host splenocytes to suppressor cells by tumor-induced suppressor T-cell-derived factor(s): cyclophosphamide treatment reverses inhibitory activity.
    Elgert KD; Foo AS; Burger CJ; Farrar WL
    J Biol Response Mod; 1983; 2(3):238-50. PubMed ID: 6227709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of immune responses by I-J gene products. V. Heterogeneity of I-J gene products as detected by anti-I-J monoclonal antibodies.
    Waltenbaugh C; Lei HY
    J Immunol; 1984 Oct; 133(4):1730-4. PubMed ID: 6206134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a monoclonal antibody directed to a T cell suppressor factor.
    Maier T; Stammers AT; Levy JG
    J Immunol; 1983 Oct; 131(4):1843-8. PubMed ID: 6413579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced natural killer activity in female mice after neonatal exposure to diethylstilbestrol.
    Kalland T
    J Immunol; 1980 Mar; 124(3):1297-300. PubMed ID: 7358984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC restriction and T cell receptors.
    Krammer PH
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):283-6. PubMed ID: 6975088
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of erythropoietin and cyclic nucleotides in erythroid cell proliferation in fetal liver.
    White L; Fisher JW; George WJ
    Exp Hematol; 1980; 8 Suppl 8():168-81. PubMed ID: 6297942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of polyclonal immune stimulators upon NZB.xid congenic mice.
    Smathers PA; Steinberg BJ; Reeves JP; Steinberg AD
    J Immunol; 1982 Mar; 128(3):1414-9. PubMed ID: 6976992
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between human helper and suppressor factors to a streptococcal protein antigen.
    Lehner T
    J Immunol; 1982 Nov; 129(5):1936-40. PubMed ID: 6214582
    [No Abstract]   [Full Text] [Related]  

  • 40. [Progress in the study of an interferon inducer, poly I:C, and evaluation of its clinical effects].
    Zhang LX
    Zhonghua Yi Xue Za Zhi; 1982 Aug; 62(8):502-3. PubMed ID: 6184140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.